← Back to Patent Explorer
US4617293A Expired / Lapsed US ⏱️ 0.0 years remaining

Flavonoid phosphate salts of aminoglycoside antibiotics

Assignee: Merck Patent GmbH
•
Filing: 1984-05-23
•
Granted: 1986-10-14
•
Expires: 2004-05-23
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Flavonoid phosphates of aminoglycoside antibiotics are useful sparingly soluble salts, e.g., for achieving a depot effect.

Inventors

  • 👤 Helmut Wahlig
  • 👤 Elvira Dingeldein
  • 👤 Richard Kirchlechner
  • 👤 Dieter Orth
  • 👤 Werner Rogalski

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 23:15
CPC Classifications
C; C07; C07H; C07H17/00; C07H17/04; C07H17/06; C07H17/065; C07H15/00; C07H15/20

Claims Analysis

Total Claims: 13
Claim 1
Independent Claim 11 words
A flavonoid phosphate of an aminoglycoside antibiotic, or a mixture thereof.
Claim 2
Dependent Claim 11 words
A flavonoid phosphate of an aminoglycoside antibiotic, or a mixture thereof.
Claim 3
Dependent Claim 25 words
A compound or mixture of claim 1, wherein the flavonoid phosphate is a phosphoric acid half-ester of an hydroxy-flavane, -flavene, -flavanone, -flavone or -flavylium salt.
Claim 4
Dependent Claim 17 words
A compound or mixture of claim 1 or 2, wherein the aminoglycoside antibiotic contains a deoxystreptamine unit.
Claim 5
Dependent Claim 15 words
A compound or mixture of claim 1, wherein the flavonoid phosphate is an hesperidin phosphate.
Claim 6
Dependent Claim 14 words
A compound or mixture of claim 1, wherein the flavonoid phosphate is gentamycin hesperidin-phosphate.
Claim 7
Dependent Claim 27 words
Compounds or mixtures of claim 1 selected from the group consisting of neomycin hesperidin-phosphate; paromomycin hesperidin-phosphate; sisomycin hesperidin-phosphate; amikacin hesperidin-phosphate; tobramycin hesperidin-phosphate; dibekacin hesperidin-phosphate; or streptomycin hesperidin-phosphate.
Claim 8
Dependent Claim 203 words
A compound of claim 1 wherein the flavanoid phosphate is a phosphoric acid half-ester of 6-hydroxy-4'-methoxyflavane, 6-hydroxy-3,4'-dimethoxyflavane, 6-hydroxy-4'-methoxy-3-methylflavane, catechol ((+)-3,3',4',5 7-pentahydroxyflavane), leucocianidol (3,3',4,4',5,7-hexahydroxyflavant), 2,3,3',4,4',5,7-heptahydroxyflavane glucoside, liquiritigenin (4',7-dihydroxyflavanone), pinocembrin (dihydrochrysin, 5,7-dihydroxyflavanone), naringenin (4',5,7-trihydroxyflavanone), eriodictyol (3',4',5,7-tetrahydroxyflavanone), dihydroquercetin (taxifolin, 3,3',4',5,7-pentahydroxyflavanone), 6-hydroxy-4'-methoxyflavanone, sacuranetin (4',5-dihydroxy-7-methoxy-flavanone), isosacuranetin (5,7-dihydroxy-4'-methoxy-flavanone), hesperetin (3',5,7-trihydroxy-4'-methoxy-flavanone), silibinin (2-[trans-2-(4-hydroxy-3-methoxyphenyl)-3-hydroxymethyl-1,4-benzodioxan-6-yl-]-3,5,7-trihydroxychroman-4-one), pinocembrin 7-rutinoside, sarothanoside (pinocembrin 7-neohesperidoside), salipurposide (naringenin 5-glucoside), prunin (naringenin 7-glucoside), narirutin (naringenin 7-rutinoside), naringin (naringenin 7-neohesperiodoside), eriodictin (eriodictyol 7-rhamnoside), eriocitrin (eriodictyol 7-rutinoside), eriodictyol 7-neohesperidoside, didymin (isocacuranetin 7-rutinoside), poncirin (isosacuranetin 7-neohesperidoside), persicoside (hesperitin glucoside), hesperidin (hesperetin 7-rutinoside), neohesperidin (hesperetin 7-neohesperidoside), chrysin (5,7-dihydroxyflavone), primetin (5,8-dihydroxyflavone), galangin (3,5,7-trihydroxyflavone), baicalein (5,6,7-trihydroxyflavone), apigenin (4'5,7-trihydroxyflavone), datiscetin (2',3,5,7-tetrahydroxyflavone), lotoflavin (2',4',5,7-tetrahydroxyflavone), caempferol (3,4',5,7-tetrahydroxyflavone), fisetin (3,3',4',7-tetrahydroxyflavone), luteolin (3',4',5,7-teatrahydroxyflavone), scutellarein (4',5,6,7-tetrahydroxyflavone), morin (2',4,4',5,7-pentahydroxyflavone), robinetin (3,3',4',5',7-pentahydroxyflavone), quercetin (3,3' ,4',5,7-pentahydroxyflavone), tectochrysin (5-hydroxy-7-methoxyflavone), genkwanin (4',5-dihydroxy-7-methoxyflavone), acacetin (5,7-dihydroxy-4'-methoxyflavone), diosmetin (3',5,7-trihydroxy-4'-methoxyflavone), chrysoeriol (4',5,7-trihydroxy-3'-methoxyflavone), rhamnetin (3,3',4',5-tetrahydroxy-7-methoxyflavone), isorhamnetin (3,4',5,7-tetrahydroxy-3'-methoxyflavone), chloroflavonin (3'-chloro-2',5-dihydroxy-3,7,8-trimethoxyflavone), eupatorin (3',5-dihydroxy-4',6,7-trimethoxyflavone), chrysin 7-rutinoside, chrysin 7-neohesperidoside, apiin (apigenin 7-apiosylglycoside), rhoifolin (apigenin 7-neohesperidoside), isorhoifolin (apigenin 7-rutinoside), nicotiflorin (caemferol 3-rutinoside), lespedin (caempferol 3,7-dirhamnoside), robinin (caempferol 3-robinoside 7-rhamnoside), scolymoside (lonicerin, luteolin 7-rutinoside), veronicastroside (luteolin 7-neohesperidoside), quercitrin (quercetin 3-rhamnoside), isoquercitrin (quercetin 3-glucoside), hyperoside (quercetin 3-galactoside), rutoside (rutin, quercetin 3-rutinoside), 6-hydroxymethylrutoside, monoxerutin [7-(2-hydroxyethyl)-rutoside], ethoxazorutoside [4'-O-(2-morpholinoethyl)-rutoside], troxerutin [3',4',7-tris-(2-hydroxyethyl)-rutoside], acaciin (linarin, acacetin 7-rutinoside), fortunellin (acacetin 7-neohesperidoside), diosmin (diosmetin 7-rutinoside), neodiosmin (diosmetin 7-neohesperidoside), narcissin (isorhamnetin 3-rutinoside) or keracyanin (cyanidin 3-rutinoside).
Claim 9
Dependent Claim 59 words
A compound of claim 1 wherein the aminoglycoside antibiotic is amikacin, dibekacin, gentamycin, a neomycin, paromomycin, sagamycin, sisomicin, streptomycin, tobramycin, allomycin, amicetin, apramycin, bekanamycin, betamicin, butirosin, destomycin, an everninomycin, fortimycin A or B, framycetin, homomycin, hybrimycin, hygromycin, a kanamycin, kasugamycin, lividomycin, minosaminomycin, a myomycin, netilmicin, puromycin A, ribostamycin, rimocidin, ristomycin, ristosamine, a seldomycin, sorbistin, spectinomycin, streptothricin, tunicamycin or verdamycin.
Claim 10
Dependent Claim 19 words
A pharamaceutical composition comprising an antibiotically effective amount of a compound of claim 1 and a pharmaceutically acceptable carrier.
Claim 11
Dependent Claim 32 words
In a pharmaceutical composition which is a fibrin antibiotic gel, the improvement wherein the antibiotic is a flavonoid phosphate of an aminoglycoside antibiotic, or a mixture thereof of according to claim 1.
Claim 12
Dependent Claim 25 words
A method of achieving an antibiotic effect in a patient comprising administering an antibiotically effective amount of a compound of claim 1 to the patient.
Claim 13
Dependent Claim 21 words
A method of claim 11, wherein the patient is treated with said compound for the purpose of treating a bone defect.

References Cited (Backward Citations)

US2962495A Cited
US3091572A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-10-13 1990-04-14 1990-10-14 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-10-13 1994-04-14 1994-10-14 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-10-13 1998-04-14 1998-10-14 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag